News

Please click here to see the latest news stories relating to Covid-19
 
 

Bionow members are welcome to submit PR items to this newsroom for all to see. Describing current activity and progress in the sector, it's a great place to promote your orgnaisation and keep up to date with the latest developments.

Whether currently a member or not, also keep up to date with all the latest news and events by registering to receive the Bionow newsletter.

While pharmaceuticals contribute to approximately 2% of annual air cargo volume, the industry transports over one trillion dollars’ worth of cargo every year (IATA). Pharmaceutical shipmen...

Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces that it has achieved CE-IVD marking for its Clarigene™ SARS-CoV-2 in vitro diagnostic kit, for diagnost...

While the world waits for a vaccine to be developed and approved for use against the COVID-19 virus, the best measure to identify, slow and prevent the spread of the virus is to test.

With the expansion of two of Biocair’s North American facilities, the company’s offerings in the US have increased substantially.

This bulletin aims to keep the life sciences sector up to date on the latest guidance whilst the UK is in the transition period and during the Coronavirus (COVID-19) outbreak, providing you ...

Unlike some challenges which are contained within regions, states or continents, the pandemic has sent shockwaves across the entire globe. As a result, all international supply chains have f...

The University of Liverpool, Liverpool School of Tropical Medicine and Southampton Clinical Trials Unit have announced the launch of an innovative COVID-19 drug testing platform, AGILE.

Newcastle City Council will provide much-needed business support for SMEs impacted by COVID-19.

Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces the launch of its Clarigene™ SARS-CoV-2 test for research use only (‘RUO’). The Clarigene™ SAR...

Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces that it has received CE-IVD marking for its Illumina-based IONA® test, the Company’s flagship non-inva...

Read Peak Proteins' June Newsletter - Inside Peak...

Researchers at the University of Liverpool have led the first nationwide surveillance study of the neurological complications of COVID-19.

Our Valued Sponsors & Partners